Transgenic mice expressing self major histocompatibility complex (MHC) class I (H-2K b) antigen solely in lymphoid cell lineages do not acquire tolerance to H-2K b expressed on skin grafts. H-2Kb-specific cytotoxic T cell responses were completely abrogated in these mice, even after they had rejected skin grafts. Moreover, thymocytes expressing T cell receptors that confer H-2K b reactivity on cytotoxic CD8 + T cells were eliminated. The ability to reject grafts correlated with the presence of a novel population of H-2Kb-reactive CD4 + T cells. At least some of these CD4 + T cells recognize peptides derived from H-2K b by processing. We conclude that selfMHC I antigens induce tolerance in the CD8 T cell compartment via negative selection when expressed exclusively by lymphoid cells. In contrast, tolerance to MHC class II-restricted self peptides derived by processing of such MHC I antigens is not induced in the CD4 T cell compartment. This suggests that effective transfer of self antigens from lymphoid cells to MHC II-positive cells that can process and present them as self peptides to thymocytes or CD4 + T cells does not take place in vivo. Thus, sequestration of self antigens and MHC II molecules in distinct cell types in the thymic microenvironment allows potentially autoreactive and functionally competent CD4 + T cells that recognize cryptic MHC II-restricted selfpeptides to mature into the peripheral T cell repertoire under normal physiological circumstances.
Summary
Transgenic mice expressing self major histocompatibility complex (MHC) class I (H-2K b) antigen solely in lymphoid cell lineages do not acquire tolerance to H-2K b expressed on skin grafts. H-2Kb-specific cytotoxic T cell responses were completely abrogated in these mice, even after they had rejected skin grafts. Moreover, thymocytes expressing T cell receptors that confer H-2K b reactivity on cytotoxic CD8 + T cells were eliminated. The ability to reject grafts correlated with the presence of a novel population of H-2Kb-reactive CD4 + T cells. At least some of these CD4 + T cells recognize peptides derived from H-2K b by processing. We conclude that selfMHC I antigens induce tolerance in the CD8 T cell compartment via negative selection when expressed exclusively by lymphoid cells. In contrast, tolerance to MHC class II-restricted self peptides derived by processing of such MHC I antigens is not induced in the CD4 T cell compartment. This suggests that effective transfer of self antigens from lymphoid cells to MHC II-positive cells that can process and present them as self peptides to thymocytes or CD4 + T cells does not take place in vivo. Thus, sequestration of self antigens and MHC II molecules in distinct cell types in the thymic microenvironment allows potentially autoreactive and functionally competent CD4 + T cells that recognize cryptic MHC II-restricted selfpeptides to mature into the peripheral T cell repertoire under normal physiological circumstances.
S
elf tolerance is induced in the T cell compartment by a number of mechanisms (1) (2) (3) (4) . The most effective tolerogenic mechanism is clonal deletion of self-reactive thymocytes, but the effectiveness of this mechanism depends on whether thymocytes are exposed to self antigens. Self antigens must be expressed in thymus or transferred to thymic APC from "producer" ceils in peripheral tissues. However, different APC may present distinct peptides derived from the same protein because (a) the route of antigen delivery; (b) the mechanism of antigen uptake (for extracellular proteins), and (c) differential biochemical processing pathways may all influence peptide presentation. These issues are particularly important when considering how tolerance is acquired in the CD4 T cell compartment because few cell types express MHC II constitutively in vivo. In essence, self antigens not expressed by MHC II-positive thymic cells are sequestered because peptides derived from them cannot be presented directly to thymocytes in the context of MHC II. Self antigens in this category must be transferred to MHC II-positive cells and processed into peptides that associate with MHC II. Failure to deliver self antigens from MHC II-negative producer cells to MHC II-positive APC would render self peptides invisible, or cryptic, to the CD4 T cell compartment (5, 6 ).
Intercellular transfer of some self antigens occurs via passive mechanisms. For example, complement factor C5, a blood-borne protein, is internalized, by thymic MHC IIpositive dendritic cells (DC) (7) . Presumably, cell-associated proteins cannot be transferred unless there is intimate cell-cell cocntact or cell destruction allowing neighboring MHC II-positive APC to internalize cell contents. This is an attractive scenario for murine thymocytes (MHC II negative) because large numbers of thymocytes are engulfed by thymic macrophages after, or before, their death by apoptosis (8) .
To investigate this issue, we used a set of transgenic (Tg) mice that express the murine H-2K b MHC I gene exclusively in lymphoid ceils (9, 10) . This provides a unique opportunity to investigate whether tolerance is induced in the CD4 T cell compartment by a cell-associated self antigen expressed only by MHC II-negative cells in the thymus. In this report, we describe the tolerance status of the CD4 and CD8 T cell compartments in such mice.
Materials and Methods
Mice. Mice were bred in a specific pathogen-flee facility (National Institute for Medical Research [NIMP.]). CD2Kb-3 -(9, 10) and CBK-(11) Tg mice have been described previously. TCIK-Tg mice expressing two different clonotypic receptors that confer H-2K b recognition on CD8 + T cells (BM3 and DES) have been described previously (10, 12) .
Skin Grafts. Skin grafts from CBK donor mice were applied to CD2Kb-Tg or CBA/Ca recipients using standard procedures (13) . Plaster casts protecting graft beds were removed 10 d after grafting, and grafts were inspected daily for signs of rejection.
CHofluorimetricAnalyses. lff' thymocytes were stained with biotinylated MV3 (anti-H-2K b) antibody (14) and developed with streptavidin-PE (Biogenesis, Poole, UK). Thymocytes were gated, and selected events were displayed as histograms using FACSplot software (NIMR Computing Division) using a FACScan | (Becton Dickinson & Co., Mountain View, CA) cytofluorimeter. Thymocytes from DES TCP,-Tg mice or [DES • CD2Kb-4] double-Tg mice were stained with anti-CD8-FITC and anti-CD4-PE as described previously (10) .
Generation of DC. DC-enriched cell suspensions from CBK
and CBA mice were prepared by culturing bone marrow in the presence of GM-CSF (10, 12, 15) . Cytotoxicity Assays. CD2Kb-Tg mice were injected subcutaneously with 107 irradiated splenocytes from CBK mice. After 2 wk, splenocytes from primed mice were cultured with irradiated CBK splenocytes for 5 d in vitro (9) . Responder cells were harvested and incubated, in triplicate, with EL4 (H-2 b) target cells in the ratios shown (see Fig. 3 ) for 3 h. 25 Ixl ofsupernatant was harvested from each well, and specific release of 5~Cr (Amersham, Amersham, UK) was determined (16) . (9) were set up and harvested after 4 d with the following modifications. LN responder cells were obtained from naive CD2Kb-Tg mice or from CD2Kb-Tg mice after they had rejected CBK skin grafts (primed). 2.5 • l0 s responder cells were stimulated with I0 ~ bone marrow-derived DC in flat-bottomed 96-well plates and cultured in medium containing 1% mouse serum. Cells were pulsed with 1 IxCi [3H]thymidine (Amersham) for 8 h before harvesting. In some cases, anti-CD4 antibody (GK1.5, TIB 207, a gift from Dr. R. Zamoyska, NIMR) was added. Synthetic peptide Kb[80-92] (YWERETQKAKGNE; based on the 61-69 kb peptide described in reference 17) was made by the NIM1K Peptide Synthesis Service. Peptide was added to standard proliferation assays in the amounts indicated. All assays were carried out in triplicate.
T Cell Prolferation Assays. Proliferation assays

Results
Expression of H-2I~' in CD2I~'-Tg Mia'.
CD2Kb-Tg mice carry a transgene in which transcriptional promoter elements from the human CD2 gene are joined to the H-2K L' structural gene (9) . Mice from three sublines (CD2Kb-3, CD2K6-4, CD2Kb-11) differ only in transgene copy number and chromosomal integration sites because oocytes from an inbred strain (CBA/Ca) were used to make CD2Kb-Tg mice by DNA microinjection. The CD2K b transgene drives H-2K 6 expression in lymphoid cell lineages in all CD2Kb-Tg mice. Mature B and T lymphocytes (data not shown) and thymocytes ( Fig. 1 A) express H-2K b. CD2K bTg thymocytes express "~ times more H-2K b than thymocytes from non-Tg C57BL/10 (H-2 b) mice. Myeloid cells (DC and macrophages) from CD2Kb-4 and CI)2K b-11 mice do not express H-2K b as determined by cytofluorimetric analyses (data not shown), whereas myeloid cells from CD2Kb-3 mice express H-2K 6 (10). Results from a more sensitive, T cell-dependent bioassay for H-2K b expression (12) confirm that bone marrow-derived DC from CD2Kb-4 or CD2KB-11 mice express no detectable H-2K b (Fig. 1 B) . Similar results were obtained when stimulators used in this bioassay were cultured DC or macrophages originating from spleen or thymus (18) . These results show that H-2W ~ is expressed at high level in lymphoid cell lineages in all sublines of CD2Kb-Tg mice but that expression in myeloid cell lineages occurs only in mice of the CD2KU-3 subline.
Tolerance Status cf CD2I~' T 2 Mice. Tolerance to H-2K t~
was assessed by grafting CD2Kb-Tg mice with tail skin from CBK-Tg mice (11 CBK skin grafts survived much longer on CD2Kb-4 and CD2Kb-11 recipients than on CBA recipients (Table 1) . Grafts on CD2Kb-4 and CD2Kb-11 recipients had unusual appearances before rejection in that they became dehydrated, shrank slowly in size, and were not shed. In contrast, grafts rejected by CBA recipients quickly became necrotic and were shed, as is normally observed when MHC-mismatched grafts are rejected. Qualitative differences in effector cells and/or their relative frequencies in recipient mice could explain these discrepancies.
H-2I~'-specific CD8 + T Cells Are Eliminated in CD2I~' Tg
Mice. The fate of H-2Kb-reactive thymocytes in CD2K b mice was examined by intercrossing CD2Kb-Tg mice with TCR-Tg mice (10) . The DES TCIL clonotype confers H-2K b reactivity because the DES TC1K-ix and TCR-[3 transgenes were derived from an allo-(H-2Kb)-reactive, CD8 + T cell clone (D&ir6; see reference 19) . Thymocytes from [DES X CD2Kb-4] double-Tg mice were eliminated efficiently and at an early stage in development, because the total number ofthymocytes was substantially reduced (~90%), and virtually all immature CD4+CD8 + thymocytes were eliminated (Fig. 2) . Almost all (87%) remaining thymocytes were immature CD4-CD8-thymocytes. The relatively high proportion (but low number) of mature CD4+CD8 -thymocytes probably escape deletion because of rearrangements of endogenous TCR genes 9 Almost identical results were obtained when CD2Kb-3 mice were intercrossed with BM3 or DES TCR-Tg mice (10) . Thus, thyrnocytes that recognize native cell surface-associated H-2K b molecules are eliminated in the thymus of CD2Kb-Tg mice.
More general tests for T cells that respond to H-2K b were carried out by measuring cytotoxicity generated in vitro after coculturing T cells from CD2Kb-Tg mice with irradiated stimulator cells from CBK mice. Splenocytes from CD2Kb-4 or CD2Kb-11 mice that had been immunized with CBK splenocytes before setting up MLC did not lyse target cells expressing H-2K b at levels above background (Fig. 3) , whereas T cells from immunized CBA mice lysed these targets efficiently. H-2Kb-specific cytotoxicity was not detected when responder T cells from naive CD2KB-Tg mice or CD2KB-Tg mice that had rejected CBK skin grafts were tested (data not shown). Thus, cytotoxic T cell responses were completely abrogated in CD2KB-4 and CD2KB-11 mice, even after in vivo immunization against H-2K b, and we conclude that allo-(H2Kb)-reactive T cells (mostly CD8 +) are absent in CD2K b- mice that had been immunized subcutaneously with CBK splenocytes were cocultured with CBK spleen cells and tested for cytolytic activity. 
H-2I~ Peptide-specific CD4 + T Cells Are Present in CD2I~ Tg Mice. H-2Kb~pecific T cell proliferation was
detected when LN cells from CD2Kb-4 (Fig. 4) or CD2Kb-ll (data not shown) mice were stimulated with cultured DC derived from CBK bone marrow. However, this response was detected only if LN cells were obtained from mice that had previously rejected a CBK skin graft (Fig. 4 A) or had been immunized by injection of CBK splenocytes (data not shown). Proliferative responses were abrogated completely by including anti-CD4 mAb in the culture medium (Fig. 4 B) . This shows that H-2Kb-reactive CD4 + T cells are present in CD2Kb-4 and CD2K6-11 mice.
Reasoning that H-2Kb-reactive CD4 + T cells might recognize processed H-2K b peptides presented on selfMHC II molecules (H-2A k or H-2Ek), we synthesized an H-2K b peptide (Kb [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] ) that binds to H-2A k molecules and stimulates proliferation of CD4 + T cells in CBA mice (17) . Furthermore, this peptide is produced naturally from native H-2K b protein in CBA mice since peptide-specific T cell responses were induced after immunization of CBA mice with splenocytes from B10 mice (17) . T cells from naive (unprimed) CD2Kb-4 and CD2Kb-11 mice proliferated in a dose-dependent manner when cocultured with CBA DC pulsed with Kb[80-92] peptide (Fig. 4 C) . These responses were comparable with responses made by control CBA mice to the same peptide. Thus, at least some of the H-2Kb-specific CD4 + T cells present in CD2Kb-4 and CD2Kb-ll mice recognize H-2K b peptides that bind to selfMHC II. and CD2Kb-11 mice is that thymocytes cannot present MHC II-restricted peptides because they do not express MHC II. However, tolerance to serum proteins, such as complement factor C5, is induced in the CD4 T cell compartment after C5 uptake and processing before peptide presentation on thymic MHC II-positive cells, which induces clonal deletion of C5-reactive thymocytes (7) . Transfer of proteins between cells may provide a general mechanism by which thymocytes are exposed to MHC II-restricted peptides that originate from self antigens expressed only by MHC II-negative cells. Protein transfers between cells might occur by passive uptake of antigen (as for C5) or after cell destruction and consequent release of self antigens into local microenvironments from which they are inter-nalized, processed, and presented to CD4 + thymocytes or T cells by MHC II-positive cells. This scenario may occur during necrosis, when dying cells release their contents directly into the surrounding microenvironment (21) . However, most thymocytes die by apoptosis, during which cells remain intact until scavenger macrophages engulf and destroy them (8) .
We conclude that there is no effective mechanism for transferring H-2K b molecules between thymocytes and MHC II-positive cells to present MHC II-restricted H-2K b peptides because H-2K b specific CD4 + T cells are present in CD2Kb-4 and CD2Kb-11 mice. This provides unequivocal evidence that a cell-associated self antigen expressed solely by lymphoid cells does not tolerize the CD4 T cell compartment under normal physiological conditions in vivo. This finding should be generally applicable to other self proteins that are expressed only by cells that do not express MHC II constitutively in vivo unless special factors prevent transfers of cell surface-associated proteins from thymocytes to thymic MHC II-positive cells. Under normal physiological conditions, proteins sequestered inside cells that produce them would be even less likely to be transferred to other cells than proteins such as H-2K b, which is located on the external surface of the cell membrane. If our findings are generally applicable, we predict that large numbers of self peptides that could be generated by processing of self antigens and that could bind to self MHC II are not available for tolerance induction in the CD4 T cell compartment because of (a) segregated (i.e., tissue-specific) expression of self antigens and MHC II; (b) intracellular compartmentalization of processed peptides and newly expressed MHC II, or (c) a combination of these alternatives. Exposure of such "cryptic" selfpeptides could lead to functional activation of mature CD4 + T cells, as was observed in CD2Kb-4 and CD2Kb-11 mice grafted with CBK skin. Altered physiological conditions that lead to changes in normal patterns of self protein or self MHC II expression may provide novel opportunities for transferring proteins between cells or presenting previously cryptic self peptides to T cells (5, 22, 23) . In effect, rejection of CBK skin grafts by CD2Kb-4 and CD2Kb-11 mice mimics such circumstances because there is no genetic (i.e., structural) difference between recipient and donor tissues. Cryptic H-2K b peptides are either displayed naturally by cells in the CBK graft and/or are generated as a result of inflammation after surgery.
We assume that expression of H-2K b by myeloid cells, as well as lymphoid cells in CD2Kb-3 mice, explains why these mice do not reject CBK skin grafts. Presumably, coexpression of H-2K b and MHC II molecules by thymic myeloid cells allows these cells to display processed H-2K b peptides that remain sequestered in CD2Kb-4 and CD2K b-11 mice. There is substantial evidence that peptides derived from intracellular proteins can associate with MHC II molecules synthesized in the same cells (24) (25) (26) (27) .
The role and status of B cells in CD2Kb-4 and CD2Kb-11 mice is of interest because they coexpress H-2K b and MHC II in CD2Kb-Tg mice. B cells tolerize naive, but not antigen-experienced, CD4 + T cells in vivo creating an unresponsive state (anergy) in T cells (28) . Nevertheless, naive B cells and activated B cell blasts are relatively inefficient APCs for T cell activation because they do not express adhesion and costimulatory molecules such as CD54 and CD80 (26) . Thus, even if B cells display H-2Kb-peptide/ MHC II complexes, they may not influence the tolerance status of CD4 + T cells that recognize these complexes. However, it will be interesting to examine whether the relationship between H-2K b peptide-specific CD4 + T cells and B cells in CD2Kb-4 and CD2Kb-11 mice is altered after graft rejection.
